|
1
|
Zhang CL, McKinsey TA, Chang S, et al:
Class II histone deacetylases act as signal-responsive repressors
of cardiac hypertrophy. Cell. 110:479–488. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Berridge MJ: Remodelling Ca2+
signalling systems and cardiac hypertrophy. Biochem Soc Trans.
34:228–231. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Bisping E, Ikeda S, et al: Transcription
factor GATA4 is activated but not required for insulin-like growth
factor 1 (IGF1)-induced cardiac hypertrophy. J Biol Chem.
287:9827–9834. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Toko H, Minamino T and Komuro I: Role of
heat shock transcriptional factor 1 and heat shock proteins in
cardiac hypertrophy. Trends Cardiovasc Med. 18:88–93. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Xie M and Hill JA: HDAC-dependent
ventricular remodeling. Trends Cardiovasc Med. 23:229–235. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Di Marcotullio L, Canettieri G, Infante P,
et al: Protected from the inside: endogenous histone deacetylase
inhibitors and the road to cancer. Biochim Biophys Acta.
1815:241–252. 2011.PubMed/NCBI
|
|
7
|
Agalioti T, Chen G and Thanos D:
Deciphering the transcriptional histone acetylation code for a
human gene. Cell. 111:381–392. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Hang CT, Yang J, Han P, et al: Chromatin
regulation by Brg1 underlies heart muscle development and disease.
Nature. 466:62–67. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Pedram A, Razandi M, Narayanan R, et al:
Estrogen regulates histone deacetylases to prevent cardiac
hypertrophy. Mol Biol Cell. 24:3805–3818. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Kee HJ, Sohn IS, Nam KI, et al: Inhibition
of histone deacetylation blocks cardiac hypertrophy induced by
angiotensin II infusion and aortic banding. Circulation. 113:51–59.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Prisant LM: Management of hypertension in
patients with cardiac disease: use of renin-angiotensin blocking
agents. Am J Med. 121:(8 Suppl). S8–S15. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Shimada YJ, Passeri JJ, Baggish AL, et al:
Effects of losartan on left ventricular hypertrophy and fibrosis in
patients with nonobstructive hypertrophic cardiomyopathy. JACC
Heart Fail. 1:480–487. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Li L, Zhou N, Gong H, et al: Comparison of
angiotensin II type 1-receptor blockers to regress pressure
overload-induced cardiac hypertrophy in mice. Hypertens Res.
33:1289–1297. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Gao S, Long CL, Wang RH, et al: K(ATP)
activation prevents progression of cardiac hypertrophy to failure
induced by pressure overload via protecting endothelial function.
Cardiovasc Res. 83:444–456. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Lovenberg W: Animal models for
hypertension research. Prog Clin Biol Res. 229:225–240.
1987.PubMed/NCBI
|
|
16
|
Del Ry S, Clerico A, Giannessi D, et al:
Measurement of brain natriuretic peptide in plasma samples and
cardiac tissue extracts by means of an immunoradiometric assay
method. Scand J Clin Lab Invest. 60:81–90. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wang N, Frank GD, Ding R, et al:
Promyelocytic leukemia zinc finger protein activates GATA4
transcription and mediates cardiac hypertrophic signaling from
angiotensin II receptor 2. PLoS One. 7:e356322012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Colussi C, Illi B, Rosati J, et al:
Histone deacetylase inhibitors: keeping momentum for neuromuscular
and cardiovascular diseases treatment. Pharmacol Res. 62:3–10.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Chu CH, Lo JF, Hu WS, et al: Histone
acetylation is essential for ANG-II-induced IGF-IIR gene expression
in H9c2 cardiomyoblast cells and pathologically hypertensive rat
heart. J Cell Physiol. 227:259–268. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Eom GH, Nam YS, Oh JG, et al: Regulation
of acetylation of histone deacetylase 2 by p300/CBP-associated
factor/histone deacetylase 5 in the development of cardiac
hypertrophy. Circ Res. 114:1133–1143. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Greco TM, Yu F, Guise AJ and Cristea IM:
Nuclear import of histone deacetylase 5 by requisite nuclear
localization signal phosphorylation. Mol Cell Proteomics.
10:M110.0043172011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Nader L, Lahoud L, Chouery E, et al:
B-type natriuretic peptide receptors in hypertrophied adult rat
cardiomyocytes. Ann Cardiol Angeiol (Paris). 59:20–24. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Ito H, Hiroe M, Hirata Y, et al:
Endothelin ETA receptor antagonist blocks cardiac hypertrophy
provoked by hemodynamic overload. 89:2198–2203. 1994.PubMed/NCBI
|
